Striatal function in relation to negative symptoms in schizophrenia

Psychological Medicine

Volumn 42, Issue 2, 2012, Pages 267-282

  Ehrlich, S ^a,b,c   Yendiki, A ^a   Greve, D N ^a   Manoach, D S ^a,b   Ho, B C ^d   White, T ^e   Schulz, S C ^e   Goff, D C ^b   Gollub, R L ^a,b   Holt, D J ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^d UNIVERSITY OF IOWA   (United States)

^e UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Dorsolateral prefrontal cortex; functional MRI; negative symptoms; schizophrenia; striatum

Indexed keywords

ADULT; FEMALE; FUNCTIONAL NEUROIMAGING; HUMAN; MALE; MIDDLE AGED; NEOSTRIATUM; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PHYSIOLOGY; PREFRONTAL CORTEX; SCHIZOPHRENIA; SHORT TERM MEMORY;

ADULT; FEMALE; FUNCTIONAL NEUROIMAGING; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEMORY, SHORT-TERM; MIDDLE AGED; NEOSTRIATUM; PREFRONTAL CORTEX; SCHIZOPHRENIA;

EID: 84857314705     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S003329171100119X     Document Type: Article

References (112)

1. Abi-Dargham A, Rodenhiser J, Printz D, Zea-Ponce Y, Gil R, Kegeles LS, Weiss R, Cooper TB, Mann JJ, Van Heertum RL, Gorman JM, Laruelle M (2000). Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. Proceedings of the National Academy of Sciences USA 97, 8104-8109. (Pubitemid 30460780)
2. Alexander GE, DeLong MR, Strick PL (1986). Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annual Review of Neuroscience 9, 357-381. (Pubitemid 16055790)
3. Andreasen NC (1982). Negative symptoms in schizophrenia. Definition and reliability. Archives of General Psychiatry 39, 784-788. (Pubitemid 12090301)
4. Andreasen NC (1983). Scale for the Assessment of Negative Symptoms (SANS). University of Iowa: Iowa City, IA.
5. Andreasen NC (1984). Scale for the Assessment of Positive Symptoms (SAPS). University of Iowa: Iowa City, IA.
6. Andreasen NC (1987). Psychiatric Symptoms You Currently Have-Baseline (PSYCH-BASE). University of Iowa: Iowa City, IA.
7. Andreasen NC, Pressler M, Nopoulos P, Miller D, Ho BC (2010). Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs. Biological Psychiatry 67, 255-262.
8. Annett M (1970). A classification of hand preference by association analysis. British Journal of Psychology 61, 303-321.
9. Arranz MJ, de Leon J (2007). Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research. Molecular Psychiatry 12, 707-747. (Pubitemid 47172693)
10. Ashby FG, Ell SW, Valentin VV, Casale MB (2005). FROST: a distributed neurocomputational model of working memory maintenance. Journal of Cognitive Neuroscience 17, 1728-1743.
11. Barch DM, Dowd EC (2010). Goal representations and motivational drive in schizophrenia: the role of prefrontal-striatal interactions. Schizophrenia Bulletin 36, 919-934.
12. Biver F, Goldman S, Luxen A, Delvenne V, De Maertelaer V, De La Fuente J, Mendlewicz J, Lotstra F (1995). Altered frontostriatal relationship in unmedicated schizophrenic patients. Psychiatry Research 61, 161-171.
13. Blanchard JJ, Cohen AS (2006). The structure of negative symptoms within schizophrenia: implications for assessment. Schizophrenia Bulletin 32, 238-245.
14. Blanchard JJ, Horan WP, Collins LM (2005). Examining the latent structure of negative symptoms: is there a distinct subtype of negative symptom schizophrenia? Schizophrenia Research 77, 151-165. (Pubitemid 41112209)
15. Bolam JP, Hanley JJ, Booth PA, Bevan MD (2000). Synaptic organisation of the basal ganglia. Journal of Anatomy 196, 527-542. (Pubitemid 30458775)
16. Buchanan RW (2007). Persistent negative symptoms in schizophrenia: an overview. Schizophrenia Bulletin 33, 1013-1022. (Pubitemid 47216643)
17. Buchsbaum MS, Ingvar DH, Kessler R, Waters RN, Cappelletti J, van Kammen DP, King AC, Johnson JL, Manning RG, Flynn RW, Mann LS, Bunney Jr. WE, Sokoloff L (1982). Cerebral glucography with positron tomography. Use in normal subjects and in patients with schizophrenia. Archives of General Psychiatry 39, 251-259. (Pubitemid 12142675)
18. Burbridge JA, Barch DM (2007). Anhedonia and the experience of emotion in individuals with schizophrenia. Journal of Abnormal Psychology 116, 30-42. (Pubitemid 46328613)
19. Callicott JH, Egan MF, Mattay VS, Bertolino A, Bone AD, Verchinksi B, Weinberger DR (2003). Abnormal fMRI response of the dorsolateral prefrontal cortex in cognitively intact siblings of patients with schizophrenia. American Journal of Psychiatry 160, 709-719. (Pubitemid 41079604)
20. Callicott JH, Mattay VS, Bertolino A, Finn K, Coppola R, Frank JA, Goldberg TE, Weinberger DR (1999). Physiological characteristics of capacity constraints in working memory as revealed by functional MRI. Cerebral Cortex 9, 20-26. (Pubitemid 29062016)
21. Carlsson A (1995). Neurocircuitries and neurotransmitter interactions in schizophrenia. International Clinical Psychopharmacology 10 (Suppl. 3), 21-28. (Pubitemid 26054877)
22. Carpenter Jr. WT, Heinrichs DW, Wagman AM (1988). Deficit and nondeficit forms of schizophrenia: the concept. American Journal of Psychiatry 145, 578-583.
23. Carter C, Robertson L, Nordahl T, Chaderjian M, Kraft L, O'Shora-Celaya L (1996). Spatial working memory deficits and their relationship to negative symptoms in unmedicated schizophrenia patients. Biological Psychiatry 40, 930-932. (Pubitemid 26356731)
24. Castner SA, Goldman-Rakic PS, Williams GV (2004). Animal models of working memory: insights for targeting cognitive dysfunction in schizophrenia. Psychopharmacology (Berlin) 174, 111-125. (Pubitemid 38925096)
25. Chakos MH, Lieberman JA, Bilder RM, Borenstein M, Lerner G, Bogerts B, Wu H, Kinon B, Ashtari M (1994). Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs. American Journal of Psychiatry 151, 1430-1436. (Pubitemid 24301686)
26. Chang C, Crottaz-Herbette S, Menon V (2007). Temporal dynamics of basal ganglia response and connectivity during verbal working memory. NeuroImage 34, 1253-1269. (Pubitemid 46394462)
27. Cho RY, Ford JM, Krystal JH, Laruelle M, Cuthbert B, Carter CS (2005). Functional neuroimaging and electrophysiology biomarkers for clinical trials for cognition in schizophrenia. Schizophrenia Bulletin 31, 865-869. (Pubitemid 41437779)
28. Crespo-Facorro B, Paradiso S, Andreasen NC, O'Leary DS, Watkins GL, Ponto LL, Hichwa RD (2001). Neural mechanisms of anhedonia in schizophrenia: a PET study of response to unpleasant and pleasant odors. Journal of the American Medical Association 286, 427-435. (Pubitemid 32681485)
29. Crow TJ (1985). The two-syndrome concept: origins and current status. Schizophrenia Bulletin 11, 471-486. (Pubitemid 15036191)
30. Dollfus S, Ribeyre JM, Petit M (1996). Family history and deficit form in schizophrenia. European Psychiatry 11, 260-262.
31. Dowd EC, Barch DM (2010). Anhedonia and emotional experience in schizophrenia: neural and behavioral indicators. Biological Psychiatry 67, 902-911.
32. Dunnett SB, Iversen SD (1981). Learning impairments following selective kainic acid-induced lesions within the neostriatum of rats. Behavioural Brain Research 2, 189-209. (Pubitemid 11186555)
33. Ehrlich S, Morrow EM, Roffman JL, Wallace SR, Naylor M, Bockholt HJ, Lundquist A, Yendiki A, Ho BC, White T, Manoach DS, Clark VP, Calhoun VD, Gollub RL, Holt DJ (2010). The COMT Val108/158Met polymorphism and medial temporal lobe volumetry in patients with schizophrenia and healthy adults. NeuroImage 53, 992-1000.
34. Fenton WS, Wyatt RJ, McGlashan TH (1994). Risk factors for spontaneous dyskinesia in schizophrenia. Archives of General Psychiatry 51, 643-650. (Pubitemid 24249106)
35. Fischl B, Salat DH, Busa E, Albert M, Dieterich M, Haselgrove C, van der Kouwe A, Killiany R, Kennedy D, Klaveness S, Montillo A, Makris N, Rosen B, Dale AM (2002). Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 33, 341-355. (Pubitemid 34162530)
36. Foussias G, Remington G (2010). Negative symptoms in schizophrenia: avolition and Occam's razor. Schizophrenia Bulletin 36, 359-369.
37. Friedman L, Glover GH (2006a). Reducing interscanner variability of activation in a multicenter fMRI study: controlling for signal-to-fluctuation- noise-ratio (SFNR) differences. NeuroImage 33, 471-481. (Pubitemid 44485569)
38. Friedman L, Glover GH (2006b). Report on a multicenter fMRI quality assurance protocol. Journal of Magnetic Resonance Imaging 23, 827-839. (Pubitemid 43825438)
39. Friedman L, Stern H, Brown GG, Mathalon DH, Turner J, Glover GH, Gollub RL, Lauriello J, Lim KO, Cannon T, Greve DN, Bockholt HJ, Belger A, Mueller B, Doty MJ, He J, Wells W, Smyth P, Pieper S, Kim S, Kubicki M, Vangel M, Potkin SG (2008). Test-retest and between-site reliability in a multicenter fMRI study. Human Brain Mapping 29, 958-972.
40. Galderisi S, Maj M, Mucci A, Cassano GB, Invernizzi G, Rossi A, Vita A, Dell'Osso L, Daneluzzo E, Pini S (2002). Historical, psychopathological, neurological, and neuropsychological aspects of deficit schizophrenia: a multicenter study. American Journal of Psychiatry 159, 983-990. (Pubitemid 34586944)
41. Gard DE, Kring AM, Gard MG, Horan WP, Green MF (2007). Anhedonia in schizophrenia: distinctions between anticipatory and consummatory pleasure. Schizophrenia Research 93, 253-260. (Pubitemid 46817952)
42. Goghari VM, Sponheim SR, MacDonald 3rd AW (2010). The functional neuroanatomy of symptom dimensions in schizophrenia: a qualitative and quantitative review of a persistent question. Neuroscience and Biobehavioral Reviews 34, 468-486.
43. Goldman PS, Rosvold HE (1972). The effects of selective caudate lesions in infant and juvenile Rhesus monkeys. Brain Research 43, 53-66.
44. Grace AA (2000). Gating of information flow within the limbic system and the pathophysiology of schizophrenia. Brain Research Reviews 31, 330-341. (Pubitemid 30136188)
45. Gur RE, Maany V, Mozley PD, Swanson C, Bilker W, Gur RC (1998). Subcortical MRI volumes in neuroleptic-naive and treated patients with schizophrenia. American Journal of Psychiatry 155, 1711-1717. (Pubitemid 28547495)
46. Han X, Jovicich J, Salat D, van der Kouwe A, Quinn B, Czanner S, Busa E, Pacheco J, Albert M, Killiany R, Maguire P, Rosas D, Makris N, Dale A, Dickerson B, Fischl B (2006). Reliability of MRI-derived measurements of human cerebral cortical thickness: the effects of field strength, scanner upgrade and manufacturer. NeuroImage 32, 180-194.
47. Harvey PO, Armony J, Malla A, Lepage M (2010). Functional neural substrates of self-reported physical anhedonia in non-clinical individuals and in patients with schizophrenia. Journal of Psychiatric Research 44, 707-716.
48. Harvey PO, Pruessner J, Czechowska Y, Lepage M (2007). Individual differences in trait anhedonia: a structural and functional magnetic resonance imaging study in non-clinical subjects. Molecular Psychiatry 12, 703, 767-775. (Pubitemid 47172694)
49. Heckers S, Goff D, Schacter DL, Savage CR, Fischman AJ, Alpert NM, Rauch SL (1999). Functional imaging of memory retrieval in deficit vs nondeficit schizophrenia. Archives of General Psychiatry 56, 1117-1123.
50. Herbener ES, Song W, Khine TT, Sweeney JA (2008). What aspects of emotional functioning are impaired in schizophrenia? Schizophrenia Research 98, 239-246. (Pubitemid 350235882)
51. Hollingshead A (1965). Two Factor Index of Social Position. Yale University: New Haven, CT.
52. Honer WG, Kopala LC, Rabinowitz J (2005). Extrapyramidal symptoms and signs in first-episode, antipsychotic exposed and non-exposed patients with schizophrenia or related psychotic illness. Journal of Psychopharmacology 19, 277-285. (Pubitemid 40694946)
53. Horan WP, Green MF, Kring AM, Nuechterlein KH (2006). Does anhedonia in schizophrenia reflect faulty memory for subjectively experienced emotions? Journal of Abnormal Psychology 115, 496-508. (Pubitemid 44763680)
54. Howes OD, Kapur S (2009). The dopamine hypothesis of schizophrenia: version III-the final common pathway. Schizophrenia Bulletin 35, 549-562.
55. Jansma JM, Ramsey NF, van der Wee NJ, Kahn RS (2004). Working memory capacity in schizophrenia: a parametric fMRI study. Schizophrenia Research 68, 159-171. (Pubitemid 38526140)
56. Jenkinson M, Bannister P, Brady M, Smith S (2002). Improved optimization for the robust and accurate linear registration and motion correction of brain images. NeuroImage 17, 825-841. (Pubitemid 35317016)
57. Jensen J, Willeit M, Zipursky RB, Savina I, Smith AJ, Menon M, Crawley AP, Kapur S (2008). The formation of abnormal associations in schizophrenia: neural and behavioral evidence. Neuropsychopharmacology 33, 473-479.
58. Joffe MM, Rosenbaum PR (1999). Invited commentary: propensity scores. American Journal of Epidemiology 150, 327-333. (Pubitemid 29383480)
59. Johnson MR, Morris NA, Astur RS, Calhoun VD, Mathalon DH, Kiehl KA, Pearlson GD (2006). A functional magnetic resonance imaging study of working memory abnormalities in schizophrenia. Biological Psychiatry 60, 11-21. (Pubitemid 44192422)
60. Jovicich J, Czanner S, Han X, Salat D, van der Kouwe A, Quinn B, Pacheco J, Albert M, Killiany R, Blacker D, Maguire P, Rosas D, Makris N, Gollub R, Dale A, Dickerson BC, Fischl B (2009). MRI-derived measurements of human subcortical, ventricular and intracranial brain volumes: reliability effects of scan sessions, acquisition sequences, data analyses, scanner upgrade, scanner vendors and field strengths. NeuroImage 46, 177-192.
61. Juckel G, Schlagenhauf F, Koslowski M, Filonov D, Wustenberg T, Villringer A, Knutson B, Kienast T, Gallinat J, Wrase J, Heinz A (2006a). Dysfunction of ventral striatal reward prediction in schizophrenic patients treated with typical, not atypical, neuroleptics. Psychopharmacology (Berlin) 187, 222-228. (Pubitemid 44015616)
62. Juckel G, Schlagenhauf F, Koslowski M, Wustenberg T, Villringer A, Knutson B, Wrase J, Heinz A (2006b). Dysfunction of ventral striatal reward prediction in schizophrenia. NeuroImage 29, 409-416. (Pubitemid 43063297)
63. Kegeles LS, Abi-Dargham A, Frankle WG, Gil R, Cooper TB, Slifstein M, Hwang DR, Huang Y, Haber SN, Laruelle M (2010). Increased synaptic dopamine function in associative regions of the striatum in schizophrenia. Archives of General Psychiatry 67, 231-239.
64. Keshavan MS, Bagwell WW, Haas GL, Sweeney JA, Schooler NR, Pettegrew JW (1994). Changes in caudate volume with neuroleptic treatment. Lancet 344, 1434. (Pubitemid 24365327)
65. Kim DI, Manoach DS, Mathalon DH, Turner JA, Mannell M, Brown GG, Ford JM, Gollub RL, White T, Wible C, Belger A, Bockholt HJ, Clark VP, Lauriello J, O'Leary D, Mueller BA, Lim KO, Andreasen N, Potkin SG, Calhoun VD (2009). Dysregulation of working memory and default-mode networks in schizophrenia using independent component analysis, an fBIRN and MCIC study. Human Brain Mapping 30, 3795-3811.
66. Kirkpatrick B, Buchanan RW, McKenney PD, Alphs LD, Carpenter Jr. WT (1989). The Schedule for the Deficit Syndrome: an instrument for research in schizophrenia. Psychiatry Research 30, 119-123. (Pubitemid 20005923)
67. Kirkpatrick B, Galderisi S (2008). Deficit schizophrenia: an update. World Psychiatry 7, 143-147.
68. Koch K, Wagner G, Nenadic I, Schachtzabel C, Schultz C, Roebel M, Reichenbach JR, Sauer H, Schlosser RG (2008). Fronto-striatal hypoactivation during correct information retrieval in patients with schizophrenia: an fMRI study. Neuroscience 153, 54-62.
69. Kuperberg GR, Deckersbach T, Holt DJ, Goff D, West WC (2007). Increased temporal and prefrontal activity in response to semantic associations in schizophrenia. Archives of General Psychiatry 64, 138-151. (Pubitemid 46220772)
70. Lahti AC, Holcomb HH, Medoff DR, Weiler MA, Tamminga CA, Carpenter Jr. WT (2001). Abnormal patterns of regional cerebral blood flow in schizophrenia with primary negative symptoms during an effortful auditory recognition task. American Journal of Psychiatry 158, 1797-1808. (Pubitemid 33054772)
71. Landau SM, Lal R, O'Neil JP, Baker S, Jagust WJ (2009). Striatal dopamine and working memory. Cerebral Cortex 19, 445-454.
72. Laruelle M, Abi-Dargham A (1999). Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies. Journal of Psychopharmacology 13, 358-371. (Pubitemid 30055180)
73. Laruelle M, Abi-Dargham A, van Dyck CH, Gil R, D'Souza CD, Erdos J, McCance E, Rosenblatt W, Fingado C, Zoghbi SS, Baldwin RM, Seibyl JP, Krystal JH, Charney DS, Innis RB (1996). Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proceedings of the National Academy of Sciences USA 93, 9235-9240.
74. Lewis SJ, Dove A, Robbins TW, Barker RA, Owen AM (2004). Striatal contributions to working memory: a functional magnetic resonance imaging study in humans. European Journal of Neuroscience 19, 755-760. (Pubitemid 38241314)
75. Lieberman JA, Tollefson GD, Charles C, Zipursky R, Sharma T, Kahn RS, Keefe RS, Green AI, Gur RE, McEvoy J, Perkins D, Hamer RM, Gu H, Tohen M (2005). Antipsychotic drug effects on brain morphology in first-episode psychosis. Archives of General Psychiatry 62, 361-370. (Pubitemid 40471685)
76. Magaro PA (1980). Cognition in Schizophrenia and Paranoia. Lawrence Erlbaum Associates: Hillsdale, NJ.
77. Manoach DS (2003). Prefrontal cortex dysfunction during working memory performance in schizophrenia: reconciling discrepant findings. Schizophrenia Research 60, 285-298. (Pubitemid 36184716)
78. Manoach DS, Gollub RL, Benson ES, Searl MM, Goff DC, Halpern E, Saper CB, Rauch SL (2000). Schizophrenic subjects show aberrant fMRI activation of dorsolateral prefrontal cortex and basal ganglia during working memory performance. Biological Psychiatry 48, 99-109. (Pubitemid 30618799)
79. Manoach DS, Halpern EF, Kramer TS, Chang Y, Goff DC, Rauch SL, Kennedy DN, Gollub RL (2001). Test-retest reliability of a functional MRI working memory paradigm in normal and schizophrenic subjects. American Journal of Psychiatry 158, 955-998.
80. Manoach DS, Press DZ, Thangaraj V, Searl MM, Goff DC, Halpern E, Saper CB, Warach S (1999). Schizophrenic subjects activate dorsolateral prefrontal cortex during a working memory task, as measured by fMRI. Biological Psychiatry 45, 1128-1137. (Pubitemid 29236553)
81. Middleton FA, Strick PL (2000). Basal ganglia output and cognition: evidence from anatomical, behavioral, and clinical studies. Brain and Cognition 42, 183-200. (Pubitemid 30187451)
82. Minzenberg MJ, Laird AR, Thelen S, Carter CS, Glahn DC (2009). Meta-analysis of 41 functional neuroimaging studies of executive function in schizophrenia. Archives of General Psychiatry 66, 811-822.
83. Mitsis GD, Iannetti GD, Smart TS, Tracey I, Wise RG (2008). Regions of interest analysis in pharmacological fMRI: how do the definition criteria influence the inferred result? NeuroImage 40, 121-132.
84. Mittal VA, Walker EF (2007). Movement abnormalities predict conversion to Axis I psychosis among prodromal adolescents. Journal of Abnormal Psychology 116, 796-803.
85. Morey RA, Inan S, Mitchell TV, Perkins DO, Lieberman JA, Belger A (2005). Imaging frontostriatal function in ultra-high-risk, early, and chronic schizophrenia during executive processing. Archives of General Psychiatry 62, 254-262. (Pubitemid 40990970)
86. Navari S, Dazzan P (2009). Do antipsychotic drugs affect brain structure? A systematic and critical review of MRI findings. Psychological Medicine 39, 1763-1777.
87. O'Brien LM, Ziegler DA, Deutsch CK, Kennedy DN, Goldstein JM, Seidman LJ, Hodge S, Makris N, Caviness V, Frazier JA, Herbert MR (2006). Adjustment for whole brain and cranial size in volumetric brain studies: a review of common adjustment factors and statistical methods. Harvard Review of Psychiatry 14, 141-151. (Pubitemid 43995123)
88. Onn SP, West AR, Grace AA (2000). Dopamine-mediated regulation of striatal neuronal and network interactions. Trends in Neuroscience 23, S48-S56.
89. Potkin SG, Turner JA, Brown GG, McCarthy G, Greve DN, Glover GH, Manoach DS, Belger A, Diaz M, Wible CG, Ford JM, Mathalon DH, Gollub R, Lauriello J, O'Leary D, van Erp TG, Toga AW, Preda A, Lim KO (2009). Working memory and DLPFC inefficiency in schizophrenia: the FBIRN study. Schizophrenia Bulletin 35, 19-31.
90. Roffman JL, Gollub RL, Calhoun VD, Wassink TH, Weiss AP, Ho BC, White T, Clark VP, Fries J, Andreasen NC, Goff DC, Manoach DS (2008). MTHFR 677CpT genotype disrupts prefrontal function in schizophrenia through an interaction with COMT 158Valp Met. Proceedings of the National Academy of Sciences USA 105, 17573-17578.
91. Ross DE, Kirkpatrick B, Karkowski LM, Straub RE, MacLean CJ, O'Neill FA, Compton AD, Murphy B, Walsh D, Kendler KS (2000). Sibling correlation of deficit syndrome in the Irish study of high-density schizophrenia families. American Journal of Psychiatry 157, 1071-1076. (Pubitemid 30432486)
92. Schlagenhauf F, Juckel G, Koslowski M, Kahnt T, Knutson B, Dembler T, Kienast T, Gallinat J, Wrase J, Heinz A (2008). Reward system activation in schizophrenic patients switched from typical neuroleptics to olanzapine. Psychopharmacology (Berlin) 196, 673-684.
93. Schultz W (2002). Getting formal with dopamine and reward. Neuron 36, 241-263. (Pubitemid 35217890)
94. Seeman P (1987). Dopamine receptors and the dopamine hypothesis of schizophrenia. Synapse 1, 133-152. (Pubitemid 17119661)
95. Siegel Jr. BV, Buchsbaum MS, Bunney Jr. WE, Gottschalk LA, Haier RJ, Lohr JB, Lottenberg S, Najafi A, Nuechterlein KH, Potkin SG (1993). Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients. American Journal of Psychiatry 150, 1325-1336. (Pubitemid 23259566)
96. Simon JJ, Biller A, Walther S, Roesch-Ely D, Stippich C, Weisbrod M, Kaiser S (2010). Neural correlates of reward processing in schizophrenia- relationship to apathy and depression. Schizophrenia Research 118, 154-161.
97. Smieskova R, Fusar-Poli P, Allen P, Bendfeldt K, Stieglitz RD, Drewe J, Radue EW, McGuire PK, Riecher-Rossler A, Borgwardt SJ (2009). The effects of antipsychotics on the brain: what have we learnt from structural imaging of schizophrenia? A systematic review. Current Pharmaceutical Design 15, 2535-2549.
98. Smith DA, Mar CM, Turoff BK (1998). The structure of schizophrenic symptoms: a meta-analytic confirmatory factor analysis. Schizophrenia Research 31, 57-70. (Pubitemid 28234345)
99. Smith SM (2002). Fast robust automated brain extraction. Human Brain Mapping 17, 143-155. (Pubitemid 35253488)
100. Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TE, Johansen-Berg H, Bannister PR, De Luca M, Drobnjak I, Flitney DE, Niazy RK, Saunders J, Vickers J, Zhang Y, De Stefano N, Brady JM, Matthews PM (2004). Advances in functional and structural MR image analysis and implementation as FSL. NeuroImage 23 (Suppl. 1), S208-S219. (Pubitemid 39421720)
101. Sternberg S (1969). Memory-scanning: mental processes revealed by reaction-time experiments. American Scientist 57, 421-457.
102. Tamminga CA, Thaker GK, Buchanan R, Kirkpatrick B, Alphs LD, Chase TN, Carpenter WT (1992). Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome. Archives of General Psychiatry 49, 522-530.
103. Taylor SF, Phan KL, Britton JC, Liberzon I (2005). Neural response to emotional salience in schizophrenia. Neuropsychopharmacology 30, 984-995. (Pubitemid 40570913)
104. Wacker J, Dillon DG, Pizzagalli DA (2009). The role of the nucleus accumbens and rostral anterior cingulate cortex in anhedonia: integration of resting EEG, fMRI, and volumetric techniques. NeuroImage 46, 327-337.
105. Wager TD, Smith EE (2003). Neuroimaging studies of working memory: a meta-analysis. Cognitive Affective and Behavioral Neuroscience 3, 255-274. (Pubitemid 40214833)
106. Walter H, Kammerer H, Frasch K, Spitzer M, Abler B (2009). Altered reward functions in patients on atypical antipsychotic medication in line with the revised dopamine hypothesis of schizophrenia. Psychopharmacology (Berlin) 206, 121-132.
107. White T, Magnotta VA, Bockholt HJ, Williams S, Wallace S, Ehrlich S, Mueller BA, Ho BC, Jung RE, Clark VP, Lauriello J, Bustillo JR, Schulz SC, Gollub RL, Andreasen NC, Calhoun VD, Lim KO (2010). Global white matter abnormalities in schizophrenia: a multisite diffusion tensor imaging study. Schizophrenia Bulletin 37, 222-232.
108. Whitfield-Gabrieli S (2009). Artifact Detection and QA Manual (http://web.mit.edu/swg/art/art.pdf).
109. Wilkinson G (1993). WRAT-3: Wide Range Achievement Test. Wide Range, Inc.: Wilmington, DE.
110. Wolkin A, Jaeger J, Brodie JD, Wolf AP, Fowler J, Rotrosen J, Gomez-Mont F, Cancro R (1985). Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography. American Journal of Psychiatry 142, 564-571. (Pubitemid 15034624)
111. Woolrich MW, Ripley BD, Brady M, Smith SM (2001). Temporal autocorrelation in univariate linear modeling of FMRI data. NeuroImage 14, 1370-1386. (Pubitemid 33124185)
112. Yendiki A, Greve DN, Wallace S, Vangel M, Bockholt J, Mueller BA, Magnotta V, Andreasen N, Manoach DS, Gollub RL (2010). Multi-site characterization of an fMRI working memory paradigm: reliability of activation indices. NeuroImage 53, 119-131.